您要查找的是不是：
- Human leukocyte preparation 人白细胞制剂
- The HLA (Human Leukocyte Antigen) is the major antigenic system of histocompatibility in human . 人类白细胞抗原)是人类主要组织相容性抗原系统.
- The presence of human leukocyte antigen (HLA) antibodies has been negatively associated with transplant outcome. 而人白细胞抗原（HLA）抗体的存在会对移植效果产生反作用。
- Objective: To study the origin of Sichuan Yi ethnic group according to human leukocyte antigen(HLA)-B gene frequency. 目的:根据人类白细胞抗原(HLA)-B基因频率,探讨四川彝族的民族起源。
- Objective To evaluate the relationship between atherosclerotic brain infarction (ABI) and human leukocyte antigen DR (HLA-DR) gene at molecular level. 目的探讨人白细胞DR抗原(HLA DR)基因与动脉粥样硬化性脑梗死(ABI)免疫遗传的相关性。
- Conclusion There are abnormal human leukocyte antigen DR expression on T lymphocyte and its subsets in patients with acute myocardial infarction. 提示急性心肌梗死患者T淋巴细胞表达白细胞－DR抗原异常。
- Human leukocyte antigen(HLA)-G is the non-classical human major histocompatibility complex(MHC),having limited polymorphism. HLA-G作为一种人类的主要组织相容性复合体,具有限多态性。
- Human Leukocyte Antigen (HLA) antibodies posttransplant have been associated with an increased risk of early graft failure in kidney transplants. 移植后人白细胞抗原（HLA）抗体与肾移植后早期移植物失功的高危相关。
- Objective:To study the effects of intercellular adhesion molecule 1 (ICAM 1) and human leukocyte antigen (HAL DR) on the immunopathologic process of uveitis. 目的：研究细胞间粘附分子?1（intellular adhesion m olecule?1， I C A M ?1）和人体组织相关抗原（hum an leukocyte antigen， H L A? D R）在葡萄膜炎免疫反应中的作用。
- Inadequate recognition of fetal antigens or increased sharing of human leukocyte antigens with the father may inhibit the production of anti-HLA antibodies. 母体对胎儿抗原的错误识别或与父方的HLA相容性增高，都会抑制其抗-HLA抗体的产生。
- Objective: To investigate the function and significance of human leukocyte antigen-G(HLA-G) protein in human preimplantation embryos and immunological tolerance. 摘要目的：探讨HLA-G在人类胚胎早期发育和免疫耐受中的作用和意义。
- AIM: To observe the dynamic changes in human leukocyte antigen DR (HLA-DR) antigen presentation on peripheral blood lymphocyte (PBL) of patients with postoperative pneumonia after renal transplantation and the curative efficacy of compound Qingrekeli. 目的:观察肾移植术后肺炎患者外周血淋巴细胞表面HLA-DR抗原表达的动态变化及中药复方清热颗粒的治疗效果。
- The immunological indexes were determined before and after therapy on the 1 st, 3 rd, 7 th, 14 th and 28 th day, including the changes in lymphocyte count, CD14~+ monocytes human leukocyte antigen (locus) DR (HLADR), clinical data and long-term follow-up. 分别观察治疗前及治疗后1、3、7、14和28d淋巴细胞计数和CD14+单核细胞人白细胞DR抗原(HLA DR)水平等相关免疫学指标动态变化,并收集临床资料和远期随访。
- Usually, human leukocyte antigen typing was done before kidney removal and the recipient was evaluated in the evening or at night for a transplant procedure starting in the morning. 通常，人白细胞抗原类型检测在供肾切取前已经完成，受者准备工作在傍晚或夜晚，第二天早晨进行移植。
- It's only human nature to want a comfortable life. 想过舒适的生活不过是普通人的本性。
- Human leukocyte antigen DR expression on monocytes 单核细胞人类白细胞抗原DR
- Human leukocyte antigen class I antigen HLA-I类分子
- Human leukocyte antigen class Ⅱ 人类白细胞抗原Ⅱ类复合体
- Human leukocyte antigen classⅡgenes 人类白细胞抗原基因
- Human leukocyte antigen haplotype 人类白细胞抗原半相合
